BODI vs NUS

For growth investors, Nu Skin Enterprises, Inc.

(NUS) is the stronger pick with -14. 3% revenue growth year-over-year, versus -39. 9% for The Beachbody Company, Inc. (BODI). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 2x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Nu Skin Enterprises, Inc. (NUS) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Nu Skin Enterprises, Inc.

(NUS) delivered a total return of -80. 0%, compared to -97. 2% for The Beachbody Company, Inc. (BODI). Over 10 years, the gap is even starker: NUS returned -48. 4% versus BODI's -97. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Beachbody Company, Inc.

(BODI) is the lower-risk stock at 1. 22β versus Nu Skin Enterprises, Inc. 's 1. 47β — meaning NUS is approximately 21% more volatile than BODI relative to the S&P 500. On balance sheet safety, The Beachbody Company, Inc. (BODI) carries a lower debt/equity ratio of 9% versus 45% for Nu Skin Enterprises, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nu Skin Enterprises, Inc.

(NUS) is pulling ahead at -14. 3% versus -39. 9% for The Beachbody Company, Inc. (BODI). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to 96. 1% for The Beachbody Company, Inc.. Over a 3-year CAGR, NUS leads at -12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nu Skin Enterprises, Inc.

(NUS) is the more profitable company, earning 10. 8% net margin versus -1. 1% for The Beachbody Company, Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUS leads at 6. 1% versus 3. 2% for BODI. At the gross margin level — before operating expenses — BODI leads at 73. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, NUS (3.

4% yield) pays a dividend. BODI does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Nu Skin Enterprises, Inc.

(NUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (3. 4% yield). Both have compounded well over 10 years (NUS: -48. 4%, BODI: -97. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BODI (Communication Services) and NUS (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BODI is a small-cap quality compounder stock; NUS is a small-cap deep-value stock. NUS pays a dividend while BODI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.